Abiopharma

🔍 Bagley Brittany (Director)

Company: Aurora Innovation, Inc. (AUR)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 4,847 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 408,185.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The reporting person previously elected to convert their cash retainer as an outside director into fully vested restricted stock units. The reported securities represent shares of the Issuer's Class A common stock determined by dividing the amount of the first quarter cash retainer the reporting person has earned as of March 31, 2026, by the average closing stock price of the Issuer's Class A common stock during the 20 trading-day period ending 5 business days before the grant date of April 1, 2026.